Product/Composition:- | Adenosine |
---|---|
Strength:- | 3 mg/mL |
Form:- | Intravenous (IV) Injection |
Reference Brands:- | Adenocard(US); Adenocor(EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Adenosine is a rapid-onset IV antiarrhythmic used for PSVT, available in 3 mg/mL strength (6 mg/2 mL, 12 mg/4 mL). Common brands include Adenocard, Adenocor, and Stragen. Widely used in emergency and cardiac care, adenosine is a key product on pharma B2B hospital procurement platforms.
Adenosine is a fast-acting antiarrhythmic agent used primarily for the acute treatment of paroxysmal supraventricular tachycardia (PSVT). It is administered as a rapid IV bolus and acts by slowing conduction through the AV node. Adenosine is typically available in 3 mg/mL concentration, supplied in 6 mg/2 mL and 12 mg/4 mL vials or pre-filled syringes. US brands include Adenocard and generics by Pfizer and Fresenius. In the EU, Adenocor and Adenosine Stragen are commonly used. As a critical emergency medicine, adenosine is widely procured by hospitals, emergency departments, and ICUs through pharma B2B platforms and institutional tenders.